|
USP21 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.443000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.496700E-03 |
| Normal-vs-Stage2 |
6.093900E-02 |
| Normal-vs-Stage3 |
3.88110000000275E-05 |
| Normal-vs-Stage4 |
2.963700E-03 |
| Stage1-vs-Stage2 |
9.885600E-01 |
| Stage1-vs-Stage3 |
4.388400E-02 |
| Stage1-vs-Stage4 |
4.304400E-01 |
| Stage2-vs-Stage3 |
2.503000E-01 |
| Stage2-vs-Stage4 |
6.145000E-01 |
| Stage3-vs-Stage4 |
3.833800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.82269999999508E-05 |
| Normal-vs-AfricanAmerican |
5.557000E-01 |
| Normal-vs-Asian |
1.635430E-01 |
| Caucasian-vs-AfricanAmerican |
6.237400E-03 |
| Caucasian-vs-Asian |
4.622400E-03 |
| AfricanAmerican-vs-Asian |
1.194590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.571430E-04 |
| Normal-vs-Female |
2.014100E-02 |
| Male-vs-Female |
2.557800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.543590E-01 |
| Normal-vs-Age(41-60Yrs) |
5.458600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.221300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.748360E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.899400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.523000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.676200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.514800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.432000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.324800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.126300E-02 |
| Normal-vs-Grade 2 |
4.799500E-03 |
| Normal-vs-Grade 3 |
9.82229999999529E-05 |
| Normal-vs-Grade 4 |
2.944600E-03 |
| Grade 1-vs-Grade 2 |
1.781800E-03 |
| Grade 1-vs-Grade 3 |
1.048880E-04 |
| Grade 1-vs-Grade 4 |
4.800400E-04 |
| Grade 2-vs-Grade 3 |
1.961840E-01 |
| Grade 2-vs-Grade 4 |
5.133400E-01 |
| Grade 3-vs-Grade 4 |
7.804000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.064200E-03 |
| Normal-vs-ccB subtype |
3.62270000000553E-05 |
| ccA subtype-vs-ccB subtype |
2.793700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.823500E-04 |
| Normal-vs-N1 |
8.260400E-01 |
| N0-vs-N1 |
1.094980E-01 |
|
|
